By Ella Devereux2026-07-09T12:00:00
Patients with lung disease suffered harm or died after treatment was repeatedly delayed or replaced with alternatives which had no evidence base, an independent review has found.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud